Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-12-22

Clinical Trial Update: Postprandial Effect of Chinese Tea Flavor Liquor on Selected CVD Risk Factors [Phase 1]

View source ↗

Summary

A Phase 1 trial from Zhejiang University evaluated how a Chinese tea flavor liquor affects postprandial cardiovascular risk factors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chinese Tea Flavor Liquor

Snippet

Sponsor: Zhejiang University | Conditions: Alcohols, Cardiovascular Diseases | Phase 1 | Status: COMPLETED